EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors

Zhiqian Yang iD, Yang Liu iD, Dapeng Wu iD, Bin Xu iD, Shengfa Zeng iD, Wei Zhang iD

International Journal of Endocrinology · 2026-01 · 2026 (1)

DOI: 10.1155/ije/3784550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 24.06.2026. Verfasst von Zhiqian Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Guangdong Pharmaceutical University, No. 19 Nonglinxia Road, Guangzhou, 510080, China, g…. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This investigation employed the rat GH3 somatotroph pituitary neuroendocrine tumor (PitNET) cell line to assess the effects of the antibiotic tigecycline and to preliminarily elucidate its potential molecular mechanisms.

Methods

GH3 cells were exposed to tigecycline ranging from 6.25 to 100 μM. Cell viability and IC 50 were determined using the CCK‐8 assay, and spheroid growth was monitored by measuring diameters. To assess apoptosis, cells were subjected to Annexin V‐FITC/PI staining and nuclear morphology observation after DAPI staining. Meanwhile, the cell cycle distribution was profiled via flow cytometry following propidium iodide (PI) staining. The expression of proteins related to the Akt/mTOR pathway, apoptosis, and growth hormone (GH) was evaluated by Western blot. GH secretion was quantified using ELISA.

Results

Tigecycline dose and time dependently suppressed GH3 cell proliferation, with IC 50 values of 22.45 μM at 48 h and 9.037 μM at 72 h. It also impeded three‐dimensional spheroid growth. Mechanistically, treatment induced G0/G1 phase arrest, significantly suppressed the Akt/mTOR signaling pathway (evidenced by reduced phosphorylation of Akt and mTOR), and activated the intrinsic apoptotic pathway, marked by a rise in the Bax/Bcl‐2 ratio and heightened cleaved caspase‐3 expression. Additionally, tigecycline significantly attenuated both intracellular synthesis and extracellular secretion of GH.

Conclusion

These findings indicate that tigecycline exerts potent antiproliferative and antisecretory effects on GH3 cells, likely through Akt/mTOR pathway inhibition, cell cycle arrest, and apoptosis induction. These results provide an experimental foundation for considering tigecycline as a potential therapeutic agent for GH‐secreting PitNET.

Schlagwörter

Stichwörter der Autor:innen

Akt/mTOR signaling pathwaygrowth hormonesomatotroph pituitary neuroendocrine tumor (PitNET)tigecycline

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Guangdong Pharmaceutical University, No. 19 Nonglinxia Road, Guangzhou, 510080, China, gdpu.edu.cn.
  • Guangdong Provincial Engineering and Technology Research Center of Stem Cell Therapy for Pituitary Disease, No. 19 Nonglinxia Road, Guangzhou, 510080, China.
  • Department of Neurosurgery, Huai'an Hospital, No. 19 Shanyang Road, Huai'an, 223220, China.
  • Center of Teaching Quality Monitoring and Assessment, Guangdong Pharmaceutical University, No. 280 Outer Ring East Road Guangzhou Higher Education Mega Center, Guangzhou, 510006, China, sysu.edu.cn.

ORCID-Profile: Zhiqian Yang, Yang Liu, Dapeng Wu, Bin Xu, Shengfa Zeng, Wei Zhang

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Yang, Z., Liu, Y., Wu, D., Xu, B., Zeng, S., & Zhang, W. (2026). Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/3784550

Vancouver

Yang Z, Liu Y, Wu D, Xu B, Zeng S, Zhang W. Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/3784550

BibTeX
@article{Yang2026,
  author = {Yang, Zhiqian and Liu, Yang and Wu, Dapeng and Xu, Bin and Zeng, Shengfa and Zhang, Wei},
  title = {Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors},
  journal = {International Journal of Endocrinology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ije/3784550}
}
Kostenlos starten →